Article
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
Blood - 7 May 2015
Kühnl Andrea, Valk Peter J M, Sanders Mathijs A, Ivey Adam, Hills Robert K, Mills Ken I, Gale Rosemary E, Kaiser Martin F, Dillon Richard, Joannides Melanie, Gilkes Amanda, Haferlach Torsten, Schnittger Susanne, Duprez Estelle, Linch David C, Delwel Ruud, Löwenberg Bob, Baldus Claudia D, Solomon Ellen, Burnett Alan K, Grimwade David
Abstract excerpt
The gene CXXC5 on 5q31 is frequently deleted in acute myeloid leukemia (AML) with del(5q), suggesting that inactivation of CXXC5 might play a role in leukemogenesis. Here, we investigated the functional and prognostic implications of CXXC5 expression in AML. CXXC5 mRNA was downregulated in AML with MLL rearrangements, t(8;21) and GATA2 mutations. As a mechanism of CXXC5 inactivation, we found evidence for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
